Implantation of the Jarvik 2000® left ventricular assist device using the miniaturized extracorporeal circulation system - A case report

Francesco Formica, Oluwaseun Adebayo Bamodu, Serena Mariani, Rosa Caruso, Fabio Sangalli, Giovanni Paolini

研究成果: 雜誌貢獻文章同行評審

摘要

Myocardial failure is generally considered to be a progressive, irreversible medical condition with characteristic ventricular enlargement, spatial alteration of the heart chambers, diminished cardiac inotropy and resultant dysfunctional, mechanically inefficient heart. The Jarvik 2000®, similar to the mechanical pump, is an electrically powered, axial-flow left ventricular assist device (LVAD) designed to enhance the function of the chronically failing heart and, consequently, normalize the cardiac output for a long period of time. We report the case of 70-year-old man with congestive dilated cardiomyopathy and bioprosthetic mitral valve who underwent surgical implantation of the Jarvik 2000® LVAD, using the miniaturized extracorporeal circulation (MECC) system. The LVAD was implanted through a left thoracotomy and the MECC system was used to avoid intraoperative spontaneous hemodynamic instability and/or malignant ventricular arrhythmia. The circulatory support with the MECC system was optimal and no complication in terms of hemodynamic instability and perioperative bleeding was recorded. The MECC system obliterated the adverse effects associated with conventional extracorporeal circulation, which are often fatal in critically-ill patients.
原文英語
頁(從 - 到)518-520
頁數3
期刊Perfusion
31
發行號6
DOIs
出版狀態已發佈 - 九月 1 2016

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Safety Research
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialised Nursing

指紋 深入研究「Implantation of the Jarvik 2000® left ventricular assist device using the miniaturized extracorporeal circulation system - A case report」主題。共同形成了獨特的指紋。

引用此